Intelligent Bio Solutions Inc.
INBS | NASDAQ
$1.75
-$0.01 (-0.57%)
Nov 2, 2026, 9:51 AM ET · Market open
Fiscal Year Period Ending | FY 2026 Jun 30, 2026 | FY 2025 Jun 30, 2025 | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | 4.22M | 3.05M | 3.11M | 1.26M | n/a | 1.98M |
Cost of Revenue | 2.17M | 1.81M | 1.69M | 930.2K | n/a | n/a |
Gross Profit | 2.05M | 1.25M | 1.43M | 326.67K | n/a | 1.98M |
Operating Income | -12.61M | -10.64M | -10.28M | -12.6M | -8.34M | -5.57M |
Interest Income | 110.33K | 101.52K | 84.82K | 9.68K | 14.43K | 13.81K |
Pretax Income | -12.47M | -10.6M | -10.19M | -10.66M | -8.33M | -7.06M |
Net Income | -12.43M | -10.57M | -10.16M | -10.63M | -8.31M | -7.04M |
Selling & General & Admin | 10.5M | 8.88M | 9.26M | 8.03M | 4.92M | 3.36M |
Research & Development | 3.37M | 2.4M | 1.67M | 507.42K | 3.85M | 3.84M |
Other Expenses | 784.63K | 611.04K | 776.5K | 4.39M | -437.15K | 359.2K |
Operating Expenses | 14.66M | 11.89M | 11.71M | 12.92M | 8.34M | 7.55M |
Interest Expense | 10.74K | 60.89K | 167.14K | 223.53K | 7.54K | 1.09M |
Selling & Marketing Expenses | n/a | 1.55M | 725.42K | n/a | n/a | n/a |
Cost & Expenses | 16.82M | 13.7M | 13.39M | 13.85M | 8.34M | 7.55M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.47M | 527.36K | 318.5K | 200.9K | 73.33K | 52.07K |
Shares Outstanding (Diluted) | 1.47M | 527.36K | 318.5K | 200.9K | 73.33K | 52.07K |
EPS (Basic) | -8.44 | -20 | -63.80 | -105.80 | -113.30 | -162.20 |
EPS (Diluted) | -8.44 | -20 | -63.80 | -105.80 | -113.30 | -162.20 |
EBITDA | -11.29M | -9.45M | -9.05M | -9.47M | -8.33M | n/a |
EBIT | -12.46M | -10.42M | -10.02M | -10.44M | -8.33M | -5.21M |
Depreciation & Amortization | 1.16M | 970.12K | 974.36K | 966.73K | n/a | 5.21M |
Add to Watchlist
Select watchlists to add or remove INBS